midazolam has been researched along with Glycogenosis in 1 studies
Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Djurberg, H | 1 |
Pothmann Facharzt, W | 1 |
Joseph, D | 1 |
Tjan, D | 1 |
Zuleika, M | 1 |
Ferns, S | 1 |
Rasheed, A | 1 |
Evans, DA | 1 |
Bassas, A | 1 |
1 other study available for midazolam and Glycogenosis
Article | Year |
---|---|
Anesthesia care for living-related liver transplantation for infants and children with end-stage liver disease: report of our initial experience.
Topics: Adjuvants, Anesthesia; Adult; Anesthesia, Intravenous; Atracurium; Biliary Atresia; Child; Child, Pr | 2002 |